Inventor · disambiguated record
Liang Xu
Also filed as: XU LIANG · XU LIANG-GUO
14 granted patents·13 pending applications·165 citations·filing 1998–2023
92Inventor score
Top patents by PatentIndex Score
27 records- 0193US7932382B2Conformationally constrained Smac mimetics and the uses thereofUNIV MICHIGAN·Filed 2005·Granted Apr 26, 2011·17 cites·4 claims
- 0290US7674787B2Conformationally constrained Smac mimetics and the uses thereofUNIV MICHIGAN·Filed 2005·Granted Mar 9, 2010·16 cites·4 claims
- 0387US8557812B2Small molecule inhibitors of anti-apoptotic BCL-2 family members and the uses thereofWANG SHAOMENG·Filed 2005·Granted Oct 15, 2013·9 cites·7 claims
- 0485US9074206B2Compositions and methods for micro-RNA expression profiling of colorectal cancerWU YING·Filed 2009·Granted Jul 7, 2015·15 cites·6 claims
- 0584US7432304B2Small molecule antagonists of Bcl-2 family proteinsUNIV MICHIGAN·Filed 2003·Granted Oct 7, 2008·16 cites·37 claims
- 0682US6749863B1Targeted liposome gene deliveryUNIV GEORGETOWN·Filed 1998·Granted Jun 15, 2004·62 cites·56 claims
- 0780US8859274B2Antibody fragment-targeted immunoliposomes for systemic gene deliveryXU LIANG·Filed 2006·Granted Oct 14, 2014·3 cites·6 claims
- 0880US7910621B2Small molecule antagonists of XIAP family proteinsUNIV MICHIGAN·Filed 2005·Granted Mar 22, 2011·5 cites·22 claims
- 0978US8163805B2Small molecule antagonists of Bcl-2 family proteinsWANG SHAOMENG·Filed 2008·Granted Apr 24, 2012·2 cites·20 claims
- 1076US7479276B1Antibody fragment-targeted immunoliposomes for systemic gene deliverySYNERGENE THERAPEUTICS INC·Filed 2000·Granted Jan 20, 2009·9 cites·14 claims
- 1175US8071786B2Indole compounds useful as serotonin selective agentsSARD HOWARD P·Filed 2009·Granted Dec 6, 2011·4 cites·19 claims
- 1273US8088749B2Compositions and methods for treating cancerSIMEONE DIANE·Filed 2008·Granted Jan 3, 2012·7 cites·9 claims
- 1365US2010069344A1Small molecule antagonists of bcl2 family proteinsUNIV MICHIGAN·Filed 2009·Application pending·0 cites
- 1464US2008213223A1Systemic viral/ligand gene delivery system and gene therapySYNERGENE THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 1559US2009191261A1Antibody fragment-targeted immunoliposomes for systemic gene deliverySYNERGENE THERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 1659US2005063950A1Systemic viral/ligand gene delivery system and gene therapyUNIV GEORGETOWN·Filed 2004·Application pending·0 cites
- 1756US2025205311A1Pharmaceutical compositions of semaglutide and the methods of use thereofPENTIDE THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 1855US9636419B2Targeting multiple receptors on a cell surface for specific cell targetingUNIV KANSAS·Filed 2014·Granted May 2, 2017·0 cites·17 claims
- 1952US2024425546A1Epitope ModificationNANTONG YICHEN BIOPHARMA CO LTD·Filed 2022·Application pending·0 cites
- 2052US2023131501A1THERAPEUTIC USES OF INHIBITORS OF THE RNA-BINDING PROTEIN HuRUNIV KANSAS·Filed 2021·Application pending·0 cites
- 2149US2003228677A1AMID protein, nucleic acid molecules, and uses thereofFiled 2003·Application pending·0 cites
- 2245US7655691B2Indole compounds useful as serotonin selective agentsSARD HOWARD P·Filed 2005·Granted Feb 2, 2010·0 cites·15 claims
- 2345US2022213052A1Inhibitors of rna-binding proteins, compositions thereof, and therapeutic uses therofUNIV NORTH CAROLINA CHAPEL HILL·Filed 2020·Application pending·0 cites
- 2444US2015151004A1Methods and compositions of modulating tumor initiating cells and the use thereofXU LIANG·Filed 2014·Application pending·0 cites
- 2541US2010093645A1SMAC Peptidomimetics and the Uses ThereofWANG SHAOMENG·Filed 2005·Application pending·0 cites
- 2637US2006166920A1Oligonucleotide based therapeuticsUNIV MICHIGAN·Filed 2005·Application pending·0 cites
- 2737US2021113456A1Pharmaceutical compositions of ramelteon and methods of use thereofMAXINASE LIFE SCIENCES LTD·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Liang Xu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →